Current and future clinical applications of ctDNA in immuno-oncology

JC Stadler, Y Belloum, B Deitert, M Sementsov… - Cancer Research, 2022 - AACR
Testing peripheral blood for circulating tumor DNA (ctDNA) offers a minimally invasive
opportunity to diagnose, characterize, and monitor the disease in individual cancer patients …
被引用次数：74 相关文章

Current and Future Clinical Applications of ctDNA in Immuno-Oncology

JC Stadler, Y Belloum, B Deitert, M Sementsov… - Cancer …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Testing peripheral blood for circulating tumor
DNA (ctDNA) offers a minimally invasive opportunity to diagnose, characterize, and monitor …

Current and Future Clinical Applications of ctDNA in Immuno-Oncology.

JC Stadler, Y Belloum, B Deitert, M Sementsov… - Cancer …, 2021 - europepmc.org
Testing peripheral blood for circulating tumor DNA (ctDNA) offers a minimally invasive
opportunity to diagnose, characterize, and monitor the disease in individual cancer patients …

Current and Future Clinical Applications of ctDNA in Immuno-Oncology

JC Stadler, Y Belloum, B Deitert… - Cancer …, 2022 - pubmed.ncbi.nlm.nih.gov
Testing peripheral blood for circulating tumor DNA (ctDNA) offers a minimally invasive
opportunity to diagnose, characterize, and monitor the disease in individual cancer patients …
[HTML] nih.gov

[HTML][HTML] Current and Future Clinical Applications of ctDNA in Immuno-Oncology

JC Stadler, Y Belloum, B Deitert, M Sementsov… - Cancer …, 2022 - ncbi.nlm.nih.gov
Testing peripheral blood for circulating tumor DNA (ctDNA) offers a minimally invasive
opportunity to diagnose, characterize, and monitor the disease in individual cancer patients …